Drug Information for Meaningful Use

Clinical Decision Support

Among the Eligible Professionals who are going for federal incentive payments for Meaningful Use, podiatrists rank high among early adopters. iWatch news recently published an article (http://www.iwatchnews.org/2011/10/12/6941/podiatrists-have-their-foot-door), describing this observation.

Does your EHR meet the certification requirements established by ONC? Lexicomp can help by providing your system key clinical decision support data required for certification.  As an integrated component of your EHR, our transactional drug data and reference information support the following Stage 1 meaningful use and certification criteria from ONC's Final Rule. (Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)


Lexi-Data is the foundation of Lexicomp's clinical decision support architecture. This solution provides clinical decision alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, Drug Classifications, dose range checking (adult and pediatric) and more.

 

0 Comments »

Companies developing new EMRs for small to medium healthcare settings and drug information

Drug Nomenclature

Companies developing new EMRs for small to medium healthcare settings often wait too long to consider what drug information provider to use for their product.   There are only a few drug information providers and it is advisable to know the pluses and minuses as early in the process as possible.    It is not just about drug-drug and drug-allergy interactions.  It is not just about drug dosing information,  drug nomenclature,  dosing precautions,  patient education leaflets,  branded and generic medication lists. 

It is also about which vendor is the easiest to work with.  Who will accomodate your needs and not their needs.  Who will help you resolve cerifying body issues?  Who is the best of the best when it comes to pediatric dosing?   Who will provide decision trees for black box warnings?  Who will provide easy to use APIs?   Who provides ongoing topnotch communication?  And who is at the cutting edge?    Those are just some of the quesitons you need to answer.

0 Comments »

What good are patient education leaflets if patients can't read them?

Patient Education Pamphlets

Does your EHR or patient portal include patient education pamphlets? If so, how confident are you that patients receiving the materials get the information they need? For many patients, the problem may be as basic as not understanding the language that the documents are written in.

Lexicomp is a recognized leader in patient education. Their leaflets are used in over a thousand hospitals in the U.S. and Canada. Not only are the leaflets available in 19 common languages, but they are tailored specifically to adult and pediatric patients as well. There can be huge differences in dosing, warnings, and possible adverse drug events among these populations. (Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)

Lexicomp's patient education is available for integration into a wide variety of systems -- including EHRs, EMRs, HIS systems, ePrescribing systems, patient portals, consumer websites, PMSs, and more. Contact them today using the links on this page for more information!

0 Comments »

Drug Interaction Databases for EMR and EHR developers - don't wait!

Many EMR and EHR developers wait too long to begin for looking for a supplier of drug data and drug interaction databases.  In some respects it seems like a simple chore.  There are only a few drug data providers.  But the sooner these developers start,  the better.   Why so?

First,  there is a big difference in data structure among the few providers.  Lexicomp happens to have a very simple and logical structure,  which does solve some headaches if you come in late into the game.  But even if you start in a timely way,  simpler and more logical is better. (Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)

Second,  how comprehensive is the data provided?   Consider the following needs:  drug-drug interaction,  drug-allergy interaction,  pediatric dosing information,  therapeutic dosing information,  brand vs generic,  Black-Box Warnings,  Patient Education Leaflets in multiple languages,  drug classifications,  and more.  There are many things to consider and work on before submitting your development to the certification process.  You obviously don't want any surprises.

In the last 24 months more and more EMR developers have selected Lexicomp as their drug information provider.  There are many reasons for that.   We encourage you to call early in the process.
 

0 Comments »

EMR certification requires drug interaction data that is easy to work with


Dose Administration

Many EMR vendors are scrambling to complete their products quickly so they can pass through the various certifying bodies  (their choice about who they go to).    Often overlooked early in the process is the importance of selecting the best drug information provider. Making the right selection early will save headaches later on.

It is not just a matter of drug data quality, but even more importantly about the structure of the data files and how easy those files are to work with.   It's not just about the actual drug reference database,  but about the ease of using various APIs  and working seamlessly with the data provider.   Lexicomp is quickly developing a stellar reputation in this market segment,  as is demonstrated by our growing share of the market.    There are many things that need to be considered by the EMR vendor in their search for the best provider to work with.  Some of these include the quality of pediatric dosage database, dose administation, patient education, Black Box Warning decision tree, and more.  If you are at a decision point in the area of drug information,  make sure you give Lexicomp a call. (Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)
 

0 Comments »

What are you doing about Electronic prescribing (eRx)?

ePrescribing

It is estimated that each year some 530,000 adverse drug events take place among Medicare beneficiaries alone because of drugs negatively interacting with other drugs the patient is already taking, or insufficient information about the patient’s medical history.  The Institute of Medicine (IOM) reported last year that more than 1.5 million Americans are injured annually by drug errors in hospitals, nursing homes and doctor’s offices.  These negative drug events may require costly interventions in order to stabilize the patient, including hospitalization.  


Electronic prescribing (eRx) has been recognized as an important step in moving health care from a paper-based legacy to a new electronic platform. The use of ePrescribing has been incentivized by the federal government, specifically via the Centers for Medicare and Medicaid Services (CMS). 

Lexi-Data is the foundation of Lexi-Comp's clinical decision support architecture. This solution provides patient specific alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, Drug Classifications, dose range checking (adult and pediatric) and more. (Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)

We are committed to ensuring patient safety. 
1 Comments »

Will EMR vendors make the most of the Meaningful Use reprieve?

Meaningful Use By EHR

Nothing is final yet, but in all likelihood Meaningful Use Stage 2 won't kick in until 2014. In addition, some of the draft recommendations floating around look a lot like Stage 1 with stricter compliance levels. In other words: much of the work for Stage 2 is going to fall on EPs and hospitals, rather than on EMR vendors. There will likely be some new functionality -- especially around provider-patient communication -- but probably not the crush of requirements we saw in Stage 1.

So what will EMR, EHR, and HIS vendors do with their reprieve? If they're smart, they'll take this opportunity to improve their products in ways that aren't (yet!) required by Meaningful Use but which will give them an advantage in the market. Here's some functionality that EMRs may be using this reprieve to pursue:

 

  • Implementing dose range checking: From a clinical point of view, this is one of the big gaps in what we've seen so far in the first two stages of Meaningful Use. Many of the news stories we read about adverse drug events aren't about interactions or allergies at all -- they're about mistakes in dosing. This is especially true with pediatric dosing, which can be extremely complicated. If dosage precautions were more widely implemented, patient safety would be positively affected.
  • Addressing alert fatigue: Many EMR systems are likely to live or die based on this issue alone. Whoever can figure it out will have an undeniable benefit over the competition. As with many Meaningful Use issues, it starts with drug information vendors -- does yours provide the detail needed to make alerts intelligent?
  • Improving patient education: The new recommendations for Stage 2 Meaningful Use are all about provider-patient communication. And transcripts of workgroups show that CMS and ONC are very interested in improving not just the method of communication, but the quality of information that flows through it. It seems likely that this will eventually include things like specific patient education materials for pediatric and adult patients, delivered in the language they primarily speak.

EMR vendors that can solve some or all of these issues now will find themselves ahead of the game when the next round of MU guidelines come out. Not only that, but they'll be delivering real value to clinicians that sets them apart from all the other cookie-cutter competitors who are simply "checking boxes" on the Meaningful Use checklist.

But where to start? Lexicomp is a drug and clinical information vendor who can help with all of the items listed above -- and with many more as well. Call or fill out a form today to start learning about how Lexicomp can help you build value for your users, save money and development resources, and meet government requirements for your EMR system. (Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)

 

1 Comments »

Developing a new EMR? Drug information provider and reliable pediatric dose range calculations are critical

First,  if you are developing a new EMR  or application that requires inclusion of drug and medicine information,  don't delay the process of securing a drug data vendor.  With the new certication rules you are better off finding a vendor who is easy to work with,  flexible and supportive.  There are only a few drug data providers in the market,  so it shouldn't be difficult to idenitfy them.

Secondly,  pediatric and neonatal dose ranging checking is becoming more of a must everyday.  The web-based EHR company,  Practice Fusion,  released a study earlier this year where it has been shown that EHR's  are having a real impact on the decrease of infant mortality. This is great news in general and hats off to those EHR's that have elected to focus some of their development efforts on dose range checking.

As my colleague Matt Bennardo posted several months ago, "There are drug information vendors like Lexicomp that understand there is a vast world of difference between adults and children.  Lexicomp's durg information is trusted by dozens of EMR vendors to guide clincians in prescribing, fulfilling and admnistering drugs to patients of all types --- including children." (Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)

If you are the beginning of process of developing a new EMR  or looking to modify a current EMR, contact Lexicomp for some suggestions.
 

0 Comments »

Clinicians look for pediatric dosing guidance from EMRs


Dosing in Pediatrics

Pediatric dosing continues to be a major concern among clinicians in almost all practice settings. In fact, those who do not regularly treat children often have the most questions about proper dosing and treatment. One area where EMR, EHR, and HIS systems can meaningfully differentiate themselves is in providing this information.

Physicians, pharmacists and nurses know that children are not simply "little adults". Besides different dosage precautions, children may require different administration or routes -- and for some cases may receive completely different medications. Different patient education leaflets are also needed when treating children.

For these reasons, it's important to partner with a drug information vendor that is well regarded in pediatrics. Lexicomp is the drug reference vendor of choice among U.S. pediatric hospitals, and has specialized in this area for decades. Most clinicians will see children as patients at some point in their work, and they know that this vulnerable population requires special care. Using Lexicomp as a drug vendor can help put their concerns to rest and add value to their EMR, EHR, or HIS system. 
(Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)

 

0 Comments »

A Reprise: Are you building an EMR? Does it have reliable pediatric dose range calulations?

I am reposting comments I made several months ago.  Why?  Because it is very important to build an EMR with the best pediatric dosing information possible.   The implication are clear. So,  if you are in the midst of building a new EMR or just want to include a link from your EHR over to Lexicomp Online's Pediatric Dose Range Checking,  I would suggest reading this.

Pediatric Dose Range Calculations

 

Are you building an EMR? Does it have reliable pediatric dose range calulations?

Monday, June 27, 2011 by David Wilkof

It might seem like an easy question, but the answer is neither obvious nor unimportant.  Both pediatric and neonatal dose range calculators are receiving more focus and attention.  This is serious business, with serious consequences.    Last week, Matt Bennardo wrote a blog posting where he cited a study by Practice Fusion,  where it has been shown that EHR's are having a real impact on the decrease in infant mortality.  This is great news for those EHR's that have elected to use better dose range checking calculators.  

As I said in a post last week. "All pediatric dosage calculators are not created equally.   As Matt goes on to say, "But luckily there are drug information vendors like Lexicomp that understand there is a vast world of difference between adults and children -- and often between older children and neonates. Lexicomp's drug information is trusted by dozens of EHR vendors to guide clinicians in prescribing, fulfilling, and administering drugs to patients of all types -- including children."

Lexicomp provides both "machine readable" transactional information (geared towards specific populations) for use in clinical decision support, as well as "human readable" reference materials for clinicians and patients. Even Lexicomp's patient education leaflets are written with either adult or pediatric patients in mind. 
(Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)

If you are developing an EMR or looking to improve an EHR or HIS system, I would suggest reaching out to Lexicomp for some suggestions.  Lexicomp is known for its pediatric and neonatal drug information.

 

 

 

0 Comments »

Interested in speeding up clinical decision making for physicians, nurses, and pharmacists without disrupting their workflow?

What agony when a clinician’s workflow is interrupted because they need to confirm clinical information such as a correct dose, REMS Information (Information about FDA approved Risk Evaluation and Mitigation Strategies is included in Medication Guide, REMS Components and Prescribing and Access Restriction fields),  or to find and print patient education materials. 


Our easy-to-implement Integration solutions integrate seamlessly within any hospital’s EMR, CPOE, pharmacy system, or Web portal, connecting clinicians directly Lexicomp’s trusted drug information. 
Lexicomp has integration established with many of the well know health care information system providers such as Cerner, Epic, Eclipsys, Meditech, Siemens and GE which provides one-click access to Lexicomp drug reference content such as drug monographs, patient education material which is available in 18 languages, pediatric dosing, and more. 
We have a number of options available for the integration of Lexicomp Online content which include web based URLs (APIs), Web Services, or XML Datasets. (Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)

Web API Solution
  • Our Web API solution empowers integration of all Lexicomp content. Consistent API programming calls save time and allow clinicians to launch from their internal applications into our clinical databases, utilizing whatever delivery platform they choose.
Web Services
  • Our Web Services platform is written for compatibility with Microsoft® .NET™ and Java™ programs. XML data can be obtained via standardized calls and is then processed and returned in real-time. Your application will retrieve and parse the content into your display, making complete customization a reality.

XML Datasets

  • If live Internet calls are not preferred, XML datasets are available for download from an FTP site and incorporated directly into the database.
1 Comments »

Dentistry Practice Management Systems Need Clinical Decision Support

EMR vendors are not the only ones rapidly deploying clinical decision support systems to healthcare providers. Dental professionals are demanding that their practice management systems overcome massive development hurdles in order to comply with Meaningful Use standards.

There is a buzz in the dental technology community about Meaningful Use and incorporating more clinical decision support into the practice management system workflow. If you are searching for the best dental specific drug database to integrate into your dental EMR, turn to Lexicomp. There are very few suppliers of drug data within the dental market and even fewer still that are easy to work with.  And if you are looking for an easy-to-use, out-of-the-box ePrescribing tool, trust our partner DoseSpot to deliver the solution.  What do all of these companies have in common?  They are easy to work with and provide you with the ability to get to the market fast! (Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)

Don't wait to the end of your development process to worry about:  dose range checking,  pediatric dosing, drug calculators, medicine interactions, dosage precautions, clinical guidelines, drug interaction software, duplicate therapy, drug classifications, generic drug names, drug nomenclature and more.  These are critical paths for a dental EMR build.  But it's not just about the information.  It's about who you select as your partner and who has seamless API's which makes your development easier.   

You owe it to your product and your customer to make the right choice.  

0 Comments »

Looking for Drug Information for Consumers?

Healthcare is changing more and more everyday.  There is a revolution for consumers to charge themselves with quality drug information to be better informed.  Many people do so by researching the internet for patient portals, hospital websites, among others.

If you are looking for drug information that can be easily integrated into a patient portal, reference site, or another consumer health website, Lexicomp offers a broad range of information, including adverse drug events, potential allergies, interactions, and more -- both for pediatrics and adults. Furthermore, Lexicomp has some of the best and most comprehensive patient education materials and pamphlets in the industry. (Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)

If you are interesting in are providing your customers with the best possible information, contact Lexicomp today.
0 Comments »

EMR developers searching for drug and disease information providers that are easy to work with

What do these words have in common?  "Pediatric dosing information; Medicine lists; Medicine brand names;  Drug-drug interaction;  Drug-allergy interactions; Drug interaction database; ePrescribing;  Patient education."  

There are many EMR products under development, many targeting smaller hospitals and ambulatory facilities.  There are also a number of other EMR and Practice Management products that are going through major product re-design.  Many of these development groups need to confront the decision about what drug information supplier to use.  As the title of this posting says "EMR developers are now searching for drug and disease information providers that are easy to work with" (Note: most are not).   This might not sound like a tall order, but as it turns out, it is much more difficult than they think.   It's about the data as much as it about the quality of the relationship as well as the flexibility and helpfulness of the vendor. 

How much will they help in setting up the API's?  Do they have specific pediatric dose range checking?  Do they have patient education leaflets? Are they available in foreign languages? 

                         One drug data provider stands out above else....Lexicomp.  If your serious, check them out. 
(Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)

 

0 Comments »

Does your community pharmacy have the tools to check pediatric doses?

Having a sick child can be a challenging and stressful time for any parent.  A sick child also presents challenges for health care professionals as well as health information systems as it relates to prescribing medications.  For a number of medications, pediatric dosage calculations are based on weight.  Having a weight available in the community pharmacy setting is often challenging, however this is only the first step in being able to validate the correct dosage range.  The second piece necessary to accurately check the validity of a pediatric prescription is having the correct information in your pharmacy system. 

All too often, community pharmacy systems are not equipped with the necessary drug reference database to accurately evaluate a pediatric dose.  For over 15 years, pediatric practitioners have been using Lexicomp's Pediatric Dosage Handbook and more recently, our electronic versions to prescribe and validate pediatric dosing.  Now, this information has been transformed into a data set that can be integrated into pharmacy systems to allow your HIS to help you validate these critical doses.  For more information, visit http://www.lexi.com/businesses/ehr-vendors/(Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)

0 Comments »

In Need of an Expert Pediatric Dosage Calculator? Lexicomp Can Help!

If you are in pediatrics you are most likely familiar with the Pediatric Dosage Handbook or Pediatric & Neonatal Lexi-Drugs by Lexicomp.  If you are not familiar with these resources I would highly recommend looking into these as many consider this information as the "bible" in safe pediatric dosing.  Now that Meaningful Use has been introduced and the larger overall concept of clinical decsion support and integration, Lexicomp has taken this key content and made it available as a database accessed through APIs. (Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)


Now that more and more clinical decision support resources are being integrated into the workflow, Lexicomp has invested the resources to be able to offer healthcare applications like EMR, CPOE, etc., a comprehensive database that can easily be implemented for pediatric speicific dosing and drug information, all right within the workflow.  The content from Lexicomp's pediatric information can be implemented to build pediatric dosing checks as well as a pediatric dosage calculator to ensure that pediatric and neonatal patients receive safe, accurate dosing and treatment. 

So wether you are a clinician or you are an EMR developer this information is a must have and important.  Clinicians can benefit from Lexicomp's solutions the best way they see fit.  Subscribing to our print or subscription based references or by having your EMR implement this Lexi-Data, this information cna be implemented right within your workflow. 

More information on Integrating Lexicomp content into your workflow.
 

0 Comments »

Are you building an EMR? Does it have reliable pediatric dose range calulations?

It might seem like an easy question, but the answer is neither obvious nor unimportant.  Both pediatric and neonatal dose range calculators are receiving more focus and attention.  This is serious business, with serious consequences.    Last week, Matt Bennardo wrote a blog posting where he cited a study by Practice Fusion,  where it has been shown that EHR's are having a real impact on the decrease in infant mortality.  This is great news for those EHR's that have elected to use better dose range checking calculators.  

As I said in a post last week. "All pediatric dosage calculators are not created equally.   As Matt goes on to say, "But luckily there are drug information vendors like Lexicomp that understand there is a vast world of difference between adults and children -- and often between older children and neonates. Lexicomp's drug information is trusted by dozens of EHR vendors to guide clinicians in prescribing, fulfilling, and administering drugs to patients of all types -- including children."

Lexicomp provides both "machine readable" transactional information (geared towards specific populations) for use in clinical decision support, as well as "human readable" reference materials for clinicians and patients. Even Lexicomp's patient education leaflets are written with either adult or pediatric patients in mind.

If you are developing an EMR or looking to improve an EHR or HIS system, I would suggest reaching out to Lexicomp for some suggestions.  Lexicomp is known for its pediatric and neonatal drug information. 
(Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)

 

0 Comments »

Can you rely on your HIS and EMR to check your pediatric dosage calculations?

Matt Bennardo had a great blog post last week where he wrote about the positive benefits of Meaningful Use on the development of EHRs and their impact on patient safety.  He cites a study by Practice Fusion,  where it has been shown that EHR's are having a real impact on the decrease in infant mortality.  This is great news!

As Matt wrote, "Of course, to get these kinds of results, the information in the EHR needs to be accurate, timely, complete, actionable, and specific to the patient. With respect to pediatric and neonatal patients, that last point is especially important. An EHR that is only set up to perform dose range checking and interaction checking on adults won't be nearly as helpful when it comes to children."

All pediatric dosage calculators are not created equally.   As Matt goes on to say, "But luckily there are drug information vendors like Lexicomp that understand there is a vast world of difference between adults and children -- and often between older children and neonates. Lexicomp's drug information is trusted by dozens of EHR vendors to guide clinicians in prescribing, fulfilling, and administering drugs to patients of all types -- including children.

Lexicomp provides both "machine readable" transactional information (geared towards specific populations) for use in clinical decision support, as well as "human readable" reference materials for clinicians and patients. Even Lexicomp's patient education leaflets are written with either adult or pediatric patients in mind. 
(Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)

If you are developing an EMR or looking to improve an EHR or HIS system, I would suggest reaching out to Lexicomp for some suggestions.

 

 

 

 

0 Comments »

Even more EHR growth than expected!!

Back in January of this year, I wrote about the steady increase of Electronic Health Records/Electronic Medical Records with the market projected to be at $3.8 billion in 2015.  Now, according to this report, "The U.S. EMR market is expected to grow from $2,177 million in 2009 to $6,054 million in 2015."  This number is almost double!! 

 
 

What I said back in January continues to apply today, as it is still not too late to get your software certified with trusted drug data.  Don't wait until the end of your development process to worry about: medicine interactions, a drug reference database, pediatric dosing, dose ranges and more.  But it's not just about the information.  It's about who you select as your partner and who has seamless APIs to make your job easier.  


So leave the drug content to us and know you have made the right decision.
 

0 Comments »

Dosing in Pediatrics

Matt Bennardo had a great post last week regarding a study which showed the connection between EHRs and their improvement on pediatric care.  
 
With several pediatric calculators on the market, how can one tell which to trust?  A reference book can be helpful, yet many other considerations should be taken into account.  It is vital to screen drug interactions with the full medicine list of the child along with their maturation.  Having all this information readily available with an EMR can vastly work to reduce errors.  When dealing with pediatrics, especially neonatal patients, attention to detail and continually updated, unbiased information is best.  Lexicomp has all the options to achieve improved safety for patients of any age.  (Note: The Lexicomp solution Lexi-Data referenced in this post has been replaced by newer Medi-Span solutions as of January 2013.)

These options include:
  • Pediatric Dosage Calculations in both transactional information for the clinical decision support systems and reference materials designed for clinicians.
  • Pediatric focused patient education materials

 

0 Comments »